A review of the main histopathological findings in coronavirus disease 2019

Walter O. Vasquez-Bonilla, Roberto Orozco, Víctor Argueta, Manuel Sierra, Lysien I. Zambrano, Fausto Muñoz-Lara, Dennis Salomón López-Molina, Kovy Arteaga-Livias, Zachary Grimes, Clare Bryce, Alberto Paniz-Mondolfi, Alfonso J. Rodríguez-Morales

Research output: Contribution to journalReview articlepeer-review

95 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has been declared by the World Health Organization as an emerging public health problem of global importance and classified as a pandemic. SARS-CoV-2 infection can result in diverse, multiorgan pathology, the most significant being in the lungs (diffuse alveolar damage in its different phases, microthrombi, bronchopneumonia, necrotizing bronchiolitis, viral pneumonia), heart (lymphocytic myocarditis), kidney (acute tubular injury), central nervous system (microthrombi, ischemic necrosis, acute hemorrhagic infarction, congestion, and vascular edema), lymph nodes (hemophagocytosis and histiocytosis), bone marrow (hemophagocytosis), and vasculature (deep vein thrombosis). An understanding of the spectrum and frequency of histologic findings in COVID-19 is essential for gaining a better understanding of disease pathophysiology and its ongoing impact on public health. To this end, we conducted a systematic meta-analysis of histopathologic observations to date and review the reported findings.

Original languageEnglish
Pages (from-to)74-83
Number of pages10
JournalHuman Pathology
Volume105
DOIs
StatePublished - Nov 2020

Keywords

  • Autopsy
  • COVID-19
  • Histopathology
  • Pathology
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'A review of the main histopathological findings in coronavirus disease 2019'. Together they form a unique fingerprint.

Cite this